S100A9 is expressed primarily in neutrophils and monocytes/macrophages 9, and it is highly upregulated in neutrophils and CCR2+-infiltrated macrophages at the early and late stages of TAC (Figure 2-3). The gene discussed is CCR2; the disease is persistent truncus arteriosus.